STOCK TITAN
  1. Home
  2. Sec-filings
  3. TDOC
  4. [8-K] Teladoc Health, Inc. Reports Material Event

Longtime Teladoc Health (NYSE: TDOC) director plans board exit

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Teladoc Health, Inc. reported that long-serving director Thomas G. McKinley notified the company on February 8, 2026 of his intention to retire from the Board, effective February 20, 2026. The company states that Mr. McKinley is retiring for personal reasons and not due to any disagreement with the company on any matter.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Understanding 8-K Material Events →
FALSE0001477449155 E 44th StreetSuite 1700New YorkNY1001700014774492025-10-172025-10-170001477449dei:FormerAddressMember2025-10-172025-10-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) February 8, 2026
___________________________________
Teladoc Health, Inc.
(Exact name of registrant as specified in its charter)
___________________________________

Delaware
(State or other jurisdiction of
incorporation)
001-37477
(Commission File Number)
04-3705970
(I.R.S. Employer Identification No.)
155 E 44th Street Suite 1700
New York, NY 10017
(Address of principal executive offices and zip code)
(203) 635-2002
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, par value $0.001 per shareTDOCThe New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company    ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 8, 2026, Mr. Thomas G. McKinley notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of February 20, 2026. Mr. McKinley has been a director of the Company since 2009 and the Company thanks him for his dedicated service. Mr. McKinley has indicated that he is retiring from the Board for personal reasons and not because of any disagreement with the Company on any matter.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 12, 2026
Teladoc Health, Inc.
By:
/s/ Adam C. Vandervoort
Name:
Adam C. Vandervoort
Title:
Chief Legal Officer and Secretary



Source: View Original Filing on SEC EDGAR

FAQ

What board change did Teladoc Health (TDOC) disclose in this 8-K?

Teladoc Health disclosed that director Thomas G. McKinley plans to retire from its Board of Directors. He notified the company on February 8, 2026, and his retirement will be effective February 20, 2026, ending a board tenure that began in 2009.

Why is Teladoc Health (TDOC) director Thomas G. McKinley retiring?

Teladoc Health reports that Thomas G. McKinley is retiring from the Board for personal reasons. The company specifically notes that his decision is not due to any disagreement with Teladoc Health on any matter, indicating an amicable separation from board service.

When will Thomas G. McKinley’s retirement from Teladoc Health’s board be effective?

Thomas G. McKinley’s retirement from Teladoc Health’s Board of Directors will be effective February 20, 2026. He informed the company of his intention to retire on February 8, 2026, providing advance notice before the effective retirement date disclosed in the filing.

How long has Thomas G. McKinley served on the Teladoc Health (TDOC) board?

Teladoc Health states that Thomas G. McKinley has been a director of the company since 2009. His planned retirement effective February 20, 2026, concludes a long period of board service, and the company publicly thanks him for his dedicated contribution.

Filing Exhibits & Attachments

4 documents

Other Documents